Bio-Rad Laboratories (BIO) Common Equity (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Common Equity of $6.9 billion for Q1 2026, up 2.57% year-over-year from $6.7 billion in Q1 2025, and down 8.08% quarter-over-quarter from $7.5 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Common Equity (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Common Equity for 18 consecutive years, with $6.9 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Common Equity rose 2.57% year-over-year to $6.9 billion; the TTM figure through Mar 2026 stood at $6.9 billion (up 2.57% YoY), while the FY2025 annual figure was $7.5 billion, up 13.46% from the prior year.
- Common Equity declined to $6.9 billion in Q1 2026 per BIO's latest filing, from $7.5 billion in the prior quarter.
- Across five years, Common Equity topped out at $10.2 billion in Q1 2022 and bottomed at $97.2 million in Q2 2025.
- Historically, Common Equity has averaged $7.7 billion across 5 years, with a median of $8.4 billion in 2023.
- On a YoY basis, Common Equity climbed as much as 13.46% in 2025 and fell as far as 98.57% in 2025.
- Bio-Rad Laboratories' Common Equity stood at $9.6 billion in 2022, then slipped by 9.09% to $8.7 billion in 2023, then decreased by 24.85% to $6.6 billion in 2024, then climbed by 13.46% to $7.5 billion in 2025, then fell by 8.08% to $6.9 billion in 2026.
- Business Quant data shows BIO's Common Equity at $6.9 billion in Q1 2026, $7.5 billion in Q4 2025, and $6.7 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 51.76 Bn |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 23.99 Bn |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 50.07 Bn |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 10.72 Bn |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 2.62 Bn |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.99 Bn |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 13.31 Bn |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 7.22 Bn |
| 10 | Bio-Rad Laboratories | 10.11 Bn | 8.49 Bn | 345.80 Mn | 7.17 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.17 Bn |
| Mar 31, 2026 | 6.85 Bn |
| Dec 31, 2025 | 7.45 Bn |
| Sep 30, 2025 | 6.74 Bn |
| Jun 30, 2025 | 97.20 Mn |
| Mar 31, 2025 | 6.68 Bn |
| Dec 31, 2024 | 6.57 Bn |
| Sep 30, 2024 | 7.49 Bn |
| Jun 30, 2024 | 6.78 Bn |
| Mar 31, 2024 | 9.05 Bn |
| Dec 31, 2023 | 8.74 Bn |
| Sep 30, 2023 | 8.42 Bn |
| Jun 30, 2023 | 8.45 Bn |
| Mar 31, 2023 | 9.76 Bn |
| Dec 31, 2022 | 9.62 Bn |
| Sep 30, 2022 | 8.48 Bn |
| Jun 30, 2022 | 8.95 Bn |
| Mar 31, 2022 | 10.20 Bn |
| Dec 31, 2021 | 13.69 Bn |
| Sep 30, 2021 | 15.33 Bn |